Immunic

Public

Immunic is now publicly traded

The data on this page reflects Immunic's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Post-IPO Financing

Mar 4, 2026

Total Funding Raised

$200M

Company Overview

Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.

AI Layer

Non-AI

Keywords

small molecule drugsoral therapiesautoimmune disease treatmentmultiple sclerosis treatmentceliac disease treatmentDHODH inhibitorvidofludimus calciumclinical-stage biotechdihydroorotate dehydrogenase inhibitorIMU-856inflammatory disease treatmentintestinal barrier functionNurr1 activatorneuroprotective therapybiopharmapharma licensingIMU-838

Immunic Comparables

Compare Immunic with similar companies based on industry and business-model similarity.

Immunic comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Immunic Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Post-IPO Financing	Mar 4, 2026

View all Funding Rounds

Immunic Investors

Notable investors and investment history

Immunic investors
Investor	Rounds
EcoR1 Capital	Post-IPO Financing
Janus Henderson Group	Post-IPO Financing
RA Capital Management	Post-IPO Financing
TCG Crossover	Post-IPO Financing
Coastlands Capital LP	Post-IPO Financing
OrbiMed	Post-IPO Financing
BVF Partners L.P.	Post-IPO Financing

View all Investors

Immunic Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Immunic Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range84

Year Founded2016

Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?